studies were analyzed to show the correlation of response with dose intensity of single-agent 5-fluorouracil ( 5-fu ) against colorectal cancer , multiagent cmf ( cyclophosphamide , methotrexate , 5-fu ) regimens against advanced breast cancer , and adjuvant therapy in stage ii breast cancer .
C0950521
cmf
C0016360
5-fu